Loading...
Burning Rock Biotech Limited
BNR•NASDAQ
Healthcare
Medical - Diagnostics & Research
$6.80
$-1.57(-18.76%)
Burning Rock Biotech Limited (BNR) Financial Performance & Income Statement Overview
Review Burning Rock Biotech Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-4.02%
↓ 4.02%
Operating Income Growth
46.58%
↑ 46.58%
Net Income Growth
46.97%
↑ 46.97%
Operating Cash Flow Growth
63.93%
↑ 63.93%
Operating Margin
-47.18%
↓ 47.18%
Gross Margin
71.49%
↑ 71.49%
Net Profit Margin
-45.59%
↓ 45.59%
ROE
-38.50%
↓ 38.50%
ROIC
-41.00%
↓ 41.00%
Burning Rock Biotech Limited (BNR) Income Statement & Financial Overview
Review Burning Rock Biotech Limited's (BNR) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $126.02M | $128.64M | $135.53M | $125.62M |
| Cost of Revenue | $36.60M | $36.80M | $40.09M | $39.93M |
| Gross Profit | $89.42M | $91.85M | $95.44M | $85.69M |
| Gross Profit Ratio | $0.71 | $0.71 | $0.70 | $0.68 |
| R&D Expenses | $52.20M | $49.15M | $64.95M | $65.98M |
| SG&A Expenses | $84.02M | $81.28M | $141.70M | $145.54M |
| Operating Expenses | $171.35M | $130.44M | $206.65M | $211.52M |
| Total Costs & Expenses | $207.95M | $167.23M | $246.75M | $251.45M |
| Interest Income | $1.81M | $3.17M | $3.19M | $4.04M |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $0.00 | $0.00 | -$262000.00 | $32.86M |
| EBITDA | -$46.80M | -$38.59M | -$111.48M | -$92.97M |
| EBITDA Ratio | -$0.37 | -$0.30 | -$0.82 | -$0.74 |
| Operating Income | -$81.93M | -$38.59M | -$111.22M | -$125.83M |
| Operating Income Ratio | -$0.65 | -$0.30 | -$0.82 | -$1.002 |
| Other Income/Expenses (Net) | $5.95M | $3.04M | $3.37M | $4.46M |
| Income Before Tax | -$75.98M | -$35.54M | -$107.85M | -$121.37M |
| Income Before Tax Ratio | -$0.60 | -$0.28 | -$0.80 | -$0.97 |
| Income Tax Expense | $5.31M | $201000.00 | $190000.00 | $180000.00 |
| Net Income | -$81.29M | -$35.74M | -$108.04M | -$121.55M |
| Net Income Ratio | -$0.65 | -$0.28 | -$0.80 | -$0.97 |
| EPS | -$79.80 | -$33.90 | -$105.70 | -$119.20 |
| Diluted EPS | -$79.80 | -$33.90 | -$105.70 | -$119.20 |
| Weighted Avg Shares Outstanding | $1.03M | $1.03M | $1.03M | $1.03M |
| Weighted Avg Shares Outstanding (Diluted) | $1.03M | $1.03M | $1.03M | $1.03M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan